ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   


By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

American Academy of Neurology 

1080 Montreal Avenue

St. Paul  Minnesota  55116  U.S.A.
Phone: 651-695-1940 Fax: 651-695-2791


SEARCH JOBS








 Company News
XenoPort, Inc. (XNPT) To Present New Data For Novel Fumarate Analog XP23829 And HORIZANT at the 66th Annual Meeting Of The American Academy of Neurology 4/24/2014 7:39:17 AM    More...
International Stem Cell Corporation To Provide An Update On Its Parkinson's Disease Program At The 66th American Academy of Neurology Annual Meeting 4/23/2014 8:59:20 AM    More...
Data From Genzyme Corporation (GENZ)’s Multiple Sclerosis Franchise Featured At American Academy of Neurology 4/22/2014 6:55:52 AM    More...
Opexa Therapeutics (OPXA) To Attend The American Academy of Neurology Annual Meeting 4/22/2014 6:52:35 AM    More...
Isis Pharmaceuticals, Inc. (ISIS) To Host Investor Event To Discuss ISIS-SMN Rx Data Presented At The 2014 American Academy of Neurology Annual Meeting 4/22/2014 6:13:50 AM    More...
New Data From Upsher-Smith Laboratories's Epilepsy Portfolio To Be Highlighted At The 66th Annual Meeting Of The American Academy of Neurology 4/21/2014 10:36:19 AM    More...
Synthetic Biologics, Inc. (SYN) Announces Rhonda Voskuhl, M.D., To Present Trimesta™ Phase II Multiple Sclerosis Clinical Trial Results At The 2014 American Academy of Neurology Annual Meeting 2/10/2014 10:08:46 AM    More...
Does Migraine Affect Income or Income Affect Migraine? American Academy of Neurology Reveals 8/29/2013 6:44:26 AM    More...
Addex Therapeutics (ADXN.SW) Announces Presentation of Dipraglurant Phase 2a Study Results at the 2013 Annual Meeting of the American Academy of Neurology 3/22/2013 8:50:49 AM    More...
Daval International Limited CSO Presents Results From an Exploratory Clinical Trial of AIMSPRO in Amyotrophic Lateral Sclerosis (ALS) at American Academy of Neurology Annual Meeting 3/21/2013 12:05:23 PM    More...
12345678910...